Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs

Since December 2019, the novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected ~435 million people and caused ~6 million related deaths as of March 2022. To combat COVID-19, there have been many attempts to repurpose FDA-appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholson, Martin W., Huang, Ching-Ying, Wang, Jyun-Yuan, Ting, Chien-Yu, Cheng, Yu-Che, Chan, Darien Z. H., Lee, Yi-Chan, Hsu, Ching-Chuan, Hsu, Yu-Hung, Chang, Cindy M. C., Hsieh, Marvin L., Cheng, Yuan-Yuan, Lin, Yi-Ling, Chen, Chien-Hsiun, Wu, Ying-Ta, Hacker, Timothy A., Wu, Joseph C., Kamp, Timothy J., Hsieh, Patrick C. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231250/
https://www.ncbi.nlm.nih.gov/pubmed/35745684
http://dx.doi.org/10.3390/ph15060765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231250/
https://www.ncbi.nlm.nih.gov/pubmed/35745684
http://dx.doi.org/10.3390/ph15060765

Ejemplares similares